In this regard, it is relevant that differences in the gut microbiome have been shown to influence susceptibility to murine and human bowel disease and to be influenced by CD1d-deficiency [61, 109]. This evidence concerns the gene CD1D and hyperinsulinemic hypoglycemia, familial, 4.